Ireland
  • Europe
  • Headlines
  • Ireland
  • World
  • Business
  • Technology
  • Entertainment
  • Sports
  • Science
  • Health

Categories

  • Artificial intelligence
  • Arts and design
  • Books
  • Business
  • Celebrities
  • Computing
  • Economy
  • Entertainment
  • Entrepreneurship
  • Environment
  • Fitness
  • Gadgets
  • Genetics
  • Headlines
  • Health
  • Healthcare
  • Internet
  • Ireland
  • Jobs
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • Nutrition
  • Personal finance
  • Physics
  • Science
  • Space
  • Sports
  • Technology
  • TV
  • Virtual reality
  • Wildlife
  • World
Ireland
  • Europe
  • Headlines
  • Ireland
  • World
  • Business
  • Technology
  • Entertainment
  • Sports
  • Science
  • Health

Browsing Tag

RHPI:REGULATORY

13 posts
MMedication
US FDA requests removal of suicide warnings from weight-loss drug labels
Read More

US FDA requests removal of suicide warnings from weight-loss drug labels

  • January 13, 2026
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
HHealth
US CDC says 2025-26 flu season ‘moderately severe’ as cases hit 11 million
Read More

US CDC says 2025-26 flu season ‘moderately severe’ as cases hit 11 million

  • January 5, 2026
Item 1 of 2 A sign advertises flu, pneumonia, and shingles vaccine shots at a Walgreens pharmacy in…
MMedication
US FDA approves Vanda Pharmaceuticals' motion sickness drug
Read More

US FDA approves Vanda Pharmaceuticals’ motion sickness drug

  • December 31, 2025
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…
MMedication
FDA approves BioCryst's oral pellet version of swelling disorder drug for children
Read More

FDA approves BioCryst’s oral pellet version of swelling disorder drug for children

  • December 12, 2025
Dec 12 (Reuters) – The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst…
MMental health
US FDA approves first at-home device for depression
Read More

US FDA approves first at-home device for depression

  • December 11, 2025
Dec 11 (Reuters) – The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device…
AArtificial intelligence
US FDA qualifies first AI tool to help speed liver disease drug development
Read More

US FDA qualifies first AI tool to help speed liver disease drug development

  • December 9, 2025
Dec 8 (Reuters) – The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed…
AArtificial intelligence
AI's rise stirs excitement, sparks job worries
Read More

AI’s rise stirs excitement, sparks job worries

  • December 5, 2025
AI’s impact on job growth and work transformation discussed at Reuters NEXT Concerns over AI’s role in job…
HHealth
Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change
Read More

Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change

  • December 2, 2025
CHICAGO, Dec 2 (Reuters) – An independent review released on Tuesday by vaccine experts of more than 400…
HHealthcare
Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer's prevention
Read More

Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention

  • November 26, 2025
More trials needed testing the drugs in people at risk of dementia, scientists say Diabetes patients on GLP-1s…
MMedication
US slashes 36% off Medicare spending on 15 high-priced medicines
Read More

US slashes 36% off Medicare spending on 15 high-priced medicines

  • November 26, 2025
Medicare says negotiated prices for 15 drugs to cut spending by 36% New prices to take effect in…
MMedication
Republican-led states challenge FDA approval of new generic abortion pill
Read More

Republican-led states challenge FDA approval of new generic abortion pill

  • November 21, 2025
Nov 20 (Reuters) – Three Republican-led states have moved to broaden their lawsuit seeking to restrict access to…
MMedication
Texas seeks to block Kenvue dividend amid Tylenol lawsuit
Read More

Texas judge in Tylenol case won’t block Kenvue’s $398 million dividend payment, lawyer says

  • November 14, 2025
Company has scheduled dividend payment for November 26 Paxton said Kenvue concealed Tylenol’s risks to kids when taken…
Ireland
www.europesays.com